National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting, 61784-61785 [06-8778]
Download as PDF
<![CDATA[
61784
Federal Register / Vol. 71, No. 202 / Thursday, October 19, 2006 / Notices
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: October 10, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8774 Filed 10–18–06; 8:45am]
Executive Blvd., Room 5B01, Rockville, MD
20892, 301–435–6889,
bhatnagg@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
BILLING CODE 4140–01–M
Dated: October 10, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8775 Filed 10–18–06; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4140–01–M
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of Closed
Meetings
cprice-sewell on PROD1PC66 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Innovative
Therapies and Clinical Studies for Screenable
Disorders.
Date: October 31, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Savoy Suites Hotel, 2505 Wisconsin
Ave., NW., Washington, DC 20007.
Contact Person: Norman Chang, PhD,
Scientific Review Administrator, Division of
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD
20892, 301–496–1485, changn@mail.nih.gov.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Maternofetal
Signaling and Lifelong Consequences.
Date: October 31, 2006.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852, (Telephone Conference Call).
Contact Person: Gopal M. Bhatnagar, PhD,
Scientific Review Administrator, Division of
Scientific Review, National Institute of Child
Health and Human Development, 6100
VerDate Aug<31>2005
14:50 Oct 18, 2006
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Child Health and
Human Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel, Genetic Factors in
Birth Defects.
Date: October 24, 2006.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6100
Executive Boulevard, Room 5B01, Rockville,
MD 20852 (Telephone Conference Call).
Contact Person: Hameed Khan, PhD,
Scientific Review Administrator, Division of
Scientific Review, National Institute of Child
Health and Human Development, NIH, 6100
Executive Blvd., Room 5B01, Bethesda, MD
20892, 301–435–6902, khanh@mail.nih.gov.
This notice is being published less
than 15 days prior to the meeting due
to the timing limitations imposed by the
review and funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: October 10, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8776 Filed 10–18–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases; Notice
of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
Board of Scientific Counselors, NIDDK.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
National Institute of Diabetes and
Digestive and Kidney Diseases,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NIDDK.
Date: November 2–3, 2006.
Time: 8:15 a.m. to 2 p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 10, 9000 Rockville Pike, Room
9S235, Bethesda, MD 20892.
Contact Person: Marvin C. Gershengorn,
MD, Scientific Director, Division of
Intramural Research, National Institute of
Diabetes and Digestive and Kidney Diseases,
National Institutes of Health, 9000 Rockville
Pike, Bldg. 10, Rm. 9N222, Bethesda, MD
20892, 301–496–4129.
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxicabs,
hotel, and airport shuttles will be
inspected before being allowed on
campus. Visitors will be asked to show
one form of identification (for example,
a government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.847, Diabetes,
E:\FR\FM\19OCN1.SGM
19OCN1
Federal Register / Vol. 71, No. 202 / Thursday, October 19, 2006 / Notices
Endocrinology and Metabolic Research;
93.848, Digestive Diseases and Nutrition
Research; 93.849, Kidney Diseases, Urology
and Hematology Research, National Institutes
of Health, HHS)
Dated: October 10, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8778 Filed 10–18–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meetings
cprice-sewell on PROD1PC66 with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel ZEB1 OSR–C J2 (P)
Point of Care Nanodiagnostics.
Date: November 13, 2006.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Suite 200 Small Conference
Room, Bethesda, MD 20892 (Telephone
Conference Call).
Contact Person: Prabha L. Atreya, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
Biomedical Imaging, and Bioengineering,
Bethesda, MD 20892, 301–496–8633,
atreyapr@mail.nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel ZEB1 OSR–C J3 (P)
Medical Image Presentation.
Date: November 17, 2006.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Suite 200 Small Conference
Room, Bethesda, MD 20892 (Telephone
Conference Call).
VerDate Aug<31>2005
16:20 Oct 18, 2006
Jkt 205001
Contact Person: Prabha L. Atreya, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
Biomedical Imaging, and Bioengineering,
Bethesda, MD 20892, 301–496–8633,
atreyapr@mail.nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel ZEB1 OSR–C J1 (P)
Integrated Microfluids.
Date: November 28, 2006.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Suite 900 Conference Room,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Prabha L. Atreya, PhD,
Scientific Review Administrator, Office of
Scientific Review, National Institute of
Biomedical Imaging, and Bioengineering,
Bethesda, MD 20892, 301–496–8633,
atreyapr@mail.nih.gov.
Dated: October 11, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8780 Filed 10–18–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
October 16, 2006, 8 a.m. to October 17,
2006, 3 p.m. Admiral Fell Inn, 888
South Broadway, Baltimore, MD 21201
which was published in the Federal
Register on September 15, 2006, 71 FR
54511–54512.
The meeting will be held October 15,
2006, 7 p.m. to October 16, 2006, 4 p.m.
The meeting location remains the same.
The meeting is closed to the public.
Dated: October 11, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–8779 Filed 10–18–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
61785
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Genetic
Associations of Complex Behaviors.
Date: October 19, 2006.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Washington Doubletree, 1515
Rhode Island Avenue NW., Washington, DC
20005.
Contact Person: Elisabeth Koss, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3152,
MSC 7770, Bethesda, MD 20892, 301–435–
0906, kosse@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, ZRG1
EMNR–G 02: Diabetes.
Date: October 26, 2006.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Abubakar A. Shaikh, PhD,
DVM, Scientific Review Administrator,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 6168, MSC 7892, Bethesda, MD 20892,
301–435–1042, shaikha@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Topics in
Vector Biology.
Date: October 27, 2006.
Time: 11 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Joseph D. Mosca, PhD,
MBA, Scientific Review Administrator,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3198, MSC 7808, Bethesda, MD 20892,
301–435–2344, moscajos@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
E:\FR\FM\19OCN1.SGM
19OCN1
]]>Agencies
[Federal Register Volume 71, Number 202 (Thursday, October 19, 2006)]
[Notices]
[Pages 61784-61785]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-8778]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of
the Board of Scientific Counselors, NIDDK.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Institute of Diabetes and Digestive and Kidney Diseases, including
consideration of personnel qualifications and performance, and the
competence of individual investigators, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, NIDDK.
Date: November 2-3, 2006.
Time: 8:15 a.m. to 2 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 10, 9000
Rockville Pike, Room 9S235, Bethesda, MD 20892.
Contact Person: Marvin C. Gershengorn, MD, Scientific Director,
Division of Intramural Research, National Institute of Diabetes and
Digestive and Kidney Diseases, National Institutes of Health, 9000
Rockville Pike, Bldg. 10, Rm. 9N222, Bethesda, MD 20892, 301-496-
4129.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one form
of identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit.
(Catalogue of Federal Domestic Assistance Program Nos. 93.847,
Diabetes,
[[Page 61785]]
Endocrinology and Metabolic Research; 93.848, Digestive Diseases and
Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology
Research, National Institutes of Health, HHS)
Dated: October 10, 2006.
Linda Payne,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-8778 Filed 10-18-06; 8:45 am]
BILLING CODE 4140-01-M
